BioSpace News Archive

In vitro data generated by the company and its collaborators supports the ability of artemisinin, an anti-malarial drug, to inhibit SARS-CoV-2 which can lead to COVID-19 Artemisinin complements OT-101 which continues to demonstrate potent activity against SARS-CoV-2 and expands the company’s intellectual property portfolio AGOURA HILLS, Calif., April 08, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN) (“Mateon”) today announced that its COVID-19 directed antiviral screening

Samsung Biologics announced that it has been awarded the 2020 CMO Leadership Awards for its excellence in the Capabilities, Compatibility, Quality, Reliability, and Service categories across Big Pharma and Overall, making this the seventh consecutive year the company has received this distinction.

Hospital for Special Surgery has opened four urgent care centers for serious orthopedic injuries that require prompt medical attention. HSS Urgent Ortho Care has two locations on Manhattan’s Upper East Side; one on Long Island in central Nassau County; one in Stamford, Connecticut; and one in Paramus, New Jersey.

Moderna to Present at 19 th Annual Needham Healthcare Conference

Tests designed to detect both active and past infections in less than 15 minutes, using handheld Nanomix eLab Analyzer

Highlights: Phase I trial agreement with leading clinical research organization Human safety and tolerability study to assess infusion of RECCE ® 327 in 40 healthy subjects as a single ascending dose Estimated start-to-completion with data read-outs less than 12 months from now First patients expected to be dosed in second half of 2020

Global Health Trax has expanded their product line once again, adding a third tier to their venerable series of probiotic supplements.

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported its pipeline of MyoPro candidates continued to grow during the first quarter of 2020, with more than 700 candidates awaiting insurance reimbursement authorization as of March 31, 2020. This compares

System demonstrates ability to restore ventilation to acute respiratory distress syndrome-damaged lungs

Healthcare organizations have a new resource to help them solve critical revenue cycle management (RCM) challenges. The VisiQuateCOVID-19 Revenue Cycle Resource Center includes step-by-step plays and blog posts informed by the company’s deep expertise.